These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 33205222)

  • 1. Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report.
    Widysanto A; Wahyuni TD; Simanjuntak LH; Sunarso S; Siahaan SS; Haryanto H; Pandrya CO; Aritonang RCA; Gunawan C; Angela
    J Thromb Thrombolysis; 2021 Aug; 52(2):635-639. PubMed ID: 33205222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Happy hypoxia in critical COVID-19 patient: A case report in Tangerang, Indonesia.
    Widysanto A; Wahyuni TD; Simanjuntak LH; Sunarso S; Siahaan SS; Haryanto H; Pandrya CO; Aritonang RCA; Sudirman T; Christina NM; Adhiwidjaja B; Gunawan C; Angela A
    Physiol Rep; 2020 Oct; 8(20):e14619. PubMed ID: 33112512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A retrospective study on the prevalence of anti-phospholipid antibodies, thrombotic events and cutaneous signs of vasculopathy in 173 hospitalized COVID-19 patients.
    Gasparini G; Canepa P; Verdiani S; Carmisciano L; Cozzani E; De Grazia D; Andrea O; Icardi G; Parodi A
    Int J Immunopathol Pharmacol; 2021; 35():20587384211042115. PubMed ID: 34541915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Patterns and Morphology of COVID-19 Dermatology.
    Agnihothri R; Fox LP
    Dermatol Clin; 2021 Oct; 39(4):487-503. PubMed ID: 34556240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cutaneous manifestations of COVID-19 in Mexican patients: A case series and review of literature.
    Palomo-Pérez JC; Vega-Memije ME; Aguilar-Blancas D; González-Martínez E; Rangel-Gamboa L
    SAGE Open Med Case Rep; 2021; 9():2050313X21997194. PubMed ID: 33747514
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series.
    Magro CM; Mulvey JJ; Laurence J; Sanders S; Crowson AN; Grossman M; Harp J; Nuovo G
    Br J Dermatol; 2021 Jan; 184(1):141-150. PubMed ID: 32779733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.
    Genovese G; Moltrasio C; Berti E; Marzano AV
    Dermatology; 2021; 237(1):1-12. PubMed ID: 33232965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
    Rajan M B; Kumar-M P; Bhardwaj A
    Int J Dermatol; 2020 Nov; 59(11):1358-1370. PubMed ID: 32936462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disseminated intravascular coagulation: A devastating systemic disorder of special concern with COVID-19.
    Singh P; Schwartz RA
    Dermatol Ther; 2020 Nov; 33(6):e14053. PubMed ID: 32700813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin manifestations as potential symptoms of diffuse vascular injury in critical COVID-19 patients.
    Sadeghzadeh-Bazargan A; Rezai M; Najar Nobari N; Mozafarpoor S; Goodarzi A
    J Cutan Pathol; 2021 Oct; 48(10):1266-1276. PubMed ID: 33978234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
    Naderi-Azad S; Vender R
    J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. COVID-19 Skin Manifestations in Skin of Colour.
    Akuffo-Addo E; Nicholas MN; Joseph M
    J Cutan Med Surg; 2022; 26(2):189-197. PubMed ID: 34663122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous manifestations of COVID-19: Report of three cases and a review of literature.
    Sachdeva M; Gianotti R; Shah M; Bradanini L; Tosi D; Veraldi S; Ziv M; Leshem E; Dodiuk-Gad RP
    J Dermatol Sci; 2020 May; 98(2):75-81. PubMed ID: 32381430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronavirus Disease 2019 (COVID-19) and Ecchymosis: A Case Report.
    Fong JH; Koay SMA; Foo EHW; Mah YL; Eu WC
    Cureus; 2022 Mar; 14(3):e23326. PubMed ID: 35464524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive narrative review of the cutaneous manifestations associated with COVID-19.
    Arefinia N; Ghoreshi ZA; Alipour AH; Iranmanesh B; Mehrolhasani N; Shamsi-Meymandi S; Sarvari J
    Int Wound J; 2023 Mar; 20(3):871-879. PubMed ID: 36237171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Skin manifestations in patients hospitalized with confirmed COVID-19 disease: a cross-sectional study in a tertiary hospital.
    Méndez Maestro I; Peña Merino L; Udondo González Del Tánago B; Aramburu González A; Orbea Sopeña A; Sánchez De Vicente J; Ratón Nieto JA; Acebo Mariñas E; Gardeazabal García J
    Int J Dermatol; 2020 Nov; 59(11):1353-1357. PubMed ID: 32970840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential interactions of SARS-CoV-2 with human cell receptors in the skin: Understanding the enigma for a lower frequency of skin lesions compared to other tissues.
    Ricardo Criado P; Pincelli TPH; Criado RFJ; Abdalla BMZ; Belda Junior W
    Exp Dermatol; 2020 Oct; 29(10):936-944. PubMed ID: 32867008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.
    Larenas-Linnemann D; Luna-Pech J; Navarrete-Rodríguez EM; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Rio-Navarro BE; Estrada-Cardona A; Onuma-Takane E; Pozo-Beltrán CF; Valencia-Herrera AM; Ortiz-Aldana FI; Toledo-Bahena ME
    Curr Allergy Asthma Rep; 2021 Feb; 21(2):13. PubMed ID: 33630167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of sacral/buttock retiform purpura as an ominous presenting sign of COVID-19 and clinical and histopathologic evolution during severe disease course.
    McBride JD; Narang J; Simonds R; Agrawal S; Rodriguez ER; Tan CD; Baldwin WM; Dvorina N; Krywanczyk AR; Fernandez AP
    J Cutan Pathol; 2021 Sep; 48(9):1166-1172. PubMed ID: 33931901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.